Yidu Tech Inc. (2158.HK) Stock Competitors & Peer Comparison

2158.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2158.HK stands at 5B. In comparison, 0241.HK has a market cap of 54.3B. Regarding current trading prices, 2158.HK is priced at HK$4.81, while 0241.HK trades at HK$3.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2158.HK currently has a P/E ratio of 61.51, whereas 0241.HK's P/E ratio is 25.31. In terms of profitability, 2158.HK's ROE is +0.02%, compared to 0241.HK's ROE of +0.11%. Regarding short-term risk, 2158.HK is more volatile compared to 0241.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2158.HK.Check 0241.HK's competition here

2158.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2158.HK stands at 5B. In comparison, 2228.HK has a market cap of 30.9B. Regarding current trading prices, 2158.HK is priced at HK$4.81, while 2228.HK trades at HK$7.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2158.HK currently has a P/E ratio of 61.51, whereas 2228.HK's P/E ratio is -101.20. In terms of profitability, 2158.HK's ROE is +0.02%, compared to 2228.HK's ROE of +0.02%. Regarding short-term risk, 2158.HK is more volatile compared to 2228.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2158.HK.Check 2228.HK's competition here

2158.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2158.HK stands at 5B. In comparison, 1833.HK has a market cap of 15.9B. Regarding current trading prices, 2158.HK is priced at HK$4.81, while 1833.HK trades at HK$7.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2158.HK currently has a P/E ratio of 61.51, whereas 1833.HK's P/E ratio is 28.22. In terms of profitability, 2158.HK's ROE is +0.02%, compared to 1833.HK's ROE of +0.04%. Regarding short-term risk, 2158.HK is more volatile compared to 1833.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2158.HK.Check 1833.HK's competition here

2158.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2158.HK stands at 5B. In comparison, 2506.HK has a market cap of 5.3B. Regarding current trading prices, 2158.HK is priced at HK$4.81, while 2506.HK trades at HK$69.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2158.HK currently has a P/E ratio of 61.51, whereas 2506.HK's P/E ratio is -109.68. In terms of profitability, 2158.HK's ROE is +0.02%, compared to 2506.HK's ROE of N/A. Regarding short-term risk, 2158.HK is less volatile compared to 2506.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2158.HK.Check 2506.HK's competition here

2158.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2158.HK stands at 5B. In comparison, 2361.HK has a market cap of 2.1B. Regarding current trading prices, 2158.HK is priced at HK$4.81, while 2361.HK trades at HK$5.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2158.HK currently has a P/E ratio of 61.51, whereas 2361.HK's P/E ratio is 21.13. In terms of profitability, 2158.HK's ROE is +0.02%, compared to 2361.HK's ROE of N/A. Regarding short-term risk, 2158.HK is more volatile compared to 2361.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2158.HK.Check 2361.HK's competition here

2158.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2158.HK stands at 5B. In comparison, 6819.HK has a market cap of 1.8B. Regarding current trading prices, 2158.HK is priced at HK$4.81, while 6819.HK trades at HK$4.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2158.HK currently has a P/E ratio of 61.51, whereas 6819.HK's P/E ratio is -22.56. In terms of profitability, 2158.HK's ROE is +0.02%, compared to 6819.HK's ROE of -6.90%. Regarding short-term risk, 2158.HK is more volatile compared to 6819.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2158.HK.Check 6819.HK's competition here

2158.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2158.HK stands at 5B. In comparison, 2587.HK has a market cap of 1.8B. Regarding current trading prices, 2158.HK is priced at HK$4.81, while 2587.HK trades at HK$2.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2158.HK currently has a P/E ratio of 61.51, whereas 2587.HK's P/E ratio is 29.57. In terms of profitability, 2158.HK's ROE is +0.02%, compared to 2587.HK's ROE of N/A. Regarding short-term risk, 2158.HK is more volatile compared to 2587.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2158.HK.Check 2587.HK's competition here

2158.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2158.HK stands at 5B. In comparison, 2661.HK has a market cap of 1.3B. Regarding current trading prices, 2158.HK is priced at HK$4.81, while 2661.HK trades at HK$6.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2158.HK currently has a P/E ratio of 61.51, whereas 2661.HK's P/E ratio is -1.23. In terms of profitability, 2158.HK's ROE is +0.02%, compared to 2661.HK's ROE of N/A. Regarding short-term risk, 2158.HK is less volatile compared to 2661.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2158.HK.Check 2661.HK's competition here

2158.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2158.HK stands at 5B. In comparison, 2389.HK has a market cap of 496.8M. Regarding current trading prices, 2158.HK is priced at HK$4.81, while 2389.HK trades at HK$0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2158.HK currently has a P/E ratio of 61.51, whereas 2389.HK's P/E ratio is -4.28. In terms of profitability, 2158.HK's ROE is +0.02%, compared to 2389.HK's ROE of -0.06%. Regarding short-term risk, 2158.HK is less volatile compared to 2389.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2158.HK.Check 2389.HK's competition here

2158.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2158.HK stands at 5B. In comparison, 2159.HK has a market cap of 415.3M. Regarding current trading prices, 2158.HK is priced at HK$4.81, while 2159.HK trades at HK$1.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2158.HK currently has a P/E ratio of 61.51, whereas 2159.HK's P/E ratio is -6.25. In terms of profitability, 2158.HK's ROE is +0.02%, compared to 2159.HK's ROE of +0.11%. Regarding short-term risk, 2158.HK is more volatile compared to 2159.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2158.HK.Check 2159.HK's competition here

2158.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2158.HK stands at 5B. In comparison, 2415.HK has a market cap of 334M. Regarding current trading prices, 2158.HK is priced at HK$4.81, while 2415.HK trades at HK$0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2158.HK currently has a P/E ratio of 61.51, whereas 2415.HK's P/E ratio is 20.33. In terms of profitability, 2158.HK's ROE is +0.02%, compared to 2415.HK's ROE of N/A. Regarding short-term risk, 2158.HK is more volatile compared to 2415.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2158.HK.Check 2415.HK's competition here